Pulmatrix Inc Share Price Nasdaq
Equities
US74584P1030
Biotechnology & Medical Research
Sales 2022 | 6.07M 479M | Sales 2023 | 7.3M 575M | Capitalization | 6.79M 535M |
---|---|---|---|---|---|
Net income 2022 | -18M -1.42B | Net income 2023 | -14M -1.1B | EV / Sales 2022 | -3.4 x |
Net cash position 2022 | 34.77M 2.74B | Net cash position 2023 | 10.42M 821M | EV / Sales 2023 | -0.5 x |
P/E ratio 2022 |
-0.71
x | P/E ratio 2023 |
-0.48
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 02/05/17 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 17/04/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 31/10/19 |
Director/Board Member | 54 | 22/06/20 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 30/09/20 |
1st Jan change | Capi. | |
---|---|---|
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |